Keyphrases
Tumor
64%
IDH-mutant Astrocytoma
57%
Genome Analysis
50%
CNTNAP2
50%
PTPRD
50%
Oligodendroglioma
50%
Genomic Characterization
50%
Personalized Medicine
50%
High-grade Prostate Cancer
50%
Metastasis
50%
Treatment Setting
50%
Multi-sampling
50%
Origin Tracing
50%
Tumor Aggressiveness
50%
Cancer Origin
50%
Subclone
37%
Prostate Cancer
37%
Prostatectomy
25%
Evolutionary Analysis
25%
Diffuse Glioma
24%
DNA Repair Genes
20%
Tumor Progression
20%
Temozolomide
20%
Overall Survival
17%
Cancer Genome Atlas
17%
Chromosomal Rearrangements
17%
Tumor Relapse
14%
Relapsed Tumor
14%
Evolutionary
12%
Clinically Significant
12%
Primary Tumor
12%
Age 50
12%
Lymph Node Metastasis
12%
Processing Techniques
12%
Targets for Therapy
12%
Multiple Metastases
12%
Clinical Domain
12%
Biological Insight
12%
Anatomic
12%
Cancer Genomics
12%
Large Cohort
12%
Lymph Node
12%
Resistance to Therapy
12%
Cancer Progression
12%
Spatio
12%
Androgen Deprivation Therapy
12%
Genetic Drivers
12%
Clinical Trials
12%
Cancer Evolution
12%
Whole Genome
12%
Medicine and Dentistry
Neoplasm
100%
Oligoastrocytoma
55%
Oligodendroglioma
50%
Personalized Medicine
50%
Malignant Neoplasm
50%
Genome Analysis
50%
Prostate Cancer
50%
Evolution
50%
Metastatic Carcinoma
41%
Ganglioglioma
27%
Prostatectomy
25%
DNA Repair
25%
Primary Tumor
16%
Temozolomide
16%
Overall Survival
13%
The Cancer Genome Atlas
13%
Tumor Progression
8%
Lymph Node Metastasis
8%
Cell Cycle
8%
Lymph Node
8%
Clinical Trial
8%
Cohort Analysis
8%
DNA Methyltransferase 3A
8%
Cell Cycle Checkpoint
8%
Growth Factor
8%
Univariate Analysis
8%
Cancer Growth
8%
Androgen
8%
Gene Mutation
8%
Multivariate Analysis
8%
Patient Care
8%
Radiation Therapy
8%
Diseases
8%
Recurrent Disease
5%
Whole Genome Sequencing
5%
RNA Sequence
5%
Glioblastoma
5%
Gene Expression
5%
Biochemistry, Genetics and Molecular Biology
Genomics
58%
Protein Tyrosine Phosphatase Receptor Delta
50%
CNTNAP2
50%
DNA Repair
50%
Evolution
50%
Chromosomal Rearrangement
26%
Overall Survival
26%
GP5
16%
Tumor Progression
16%
Platelet Derived Growth Factor Receptor Alpha
16%
Cell Cycle Checkpoint
16%
DNMT3A
16%
Cell Cycle
16%
Growth Factor
16%
Multivariate Analysis
16%
Gene Mutation
16%
MSH2
16%
RNA Sequence
10%
Whole Genome Sequencing
10%
Gene Expression
10%
Reconstruction
8%
Clinical Trial
8%
Content Analysis
8%
Genetics
8%
Cancer Genomics
8%